Yet, EphB2/ephrin signaling was able to suppress CRC expansion and invasion via repulsive mechanisms (Lugli et al., 2005; Okumura et al., 2017; Evergren et al., 2018). Here, EPHB2 is linked to colorectal carcinoma.